What is Epiom?
Epiom operates as a physician-owned and operated entity dedicated to intraoperative neuromonitoring, a vital discipline in modern surgery. By providing real-time neurological data during high-stakes operations, the company effectively reduces the incidence of surgical complications and enhances overall patient outcomes. Their service portfolio is characterized by the deployment of board-certified clinical staff and the utilization of state-of-the-art monitoring technology. With nearly two decades of industry experience, Epiom has established itself as a trusted partner for surgeons and healthcare institutions seeking to optimize clinical efficiency while maintaining the highest standards of patient safety. The company's focus on tailored neuromonitoring solutions positions it as a key player in the intersection of medical technology and surgical risk management.
How much funding has Epiom raised?
Epiom has raised a total of $858K across 2 funding rounds:
Debt
$350K
Debt
$508K
Debt (2020): $350K with participation from PPP
Debt (2021): $508K led by PPP
Key Investors in Epiom
PPP
Public-Private Partnership
What's next for Epiom?
With the recent capital deployment, Epiom is well-positioned to accelerate its national expansion strategy. The firm is expected to focus on scaling its clinical workforce and upgrading its technological infrastructure to meet the rising demand for specialized neuromonitoring services. By prioritizing operational excellence and clinical precision, Epiom is likely to pursue further integration into major hospital systems, thereby enhancing its competitive advantage in the healthcare services market. Future growth will likely be driven by the continued adoption of its proprietary monitoring protocols, which serve to mitigate liability for hospitals while simultaneously improving the quality of care for patients undergoing complex neurological or orthopedic surgeries. The company remains committed to its core mission of delivering superior clinical outcomes through innovation and expert oversight.
See full Epiom company page
